FR2389598B1 - - Google Patents

Info

Publication number
FR2389598B1
FR2389598B1 FR7713890A FR7713890A FR2389598B1 FR 2389598 B1 FR2389598 B1 FR 2389598B1 FR 7713890 A FR7713890 A FR 7713890A FR 7713890 A FR7713890 A FR 7713890A FR 2389598 B1 FR2389598 B1 FR 2389598B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7713890A
Other versions
FR2389598A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2389598A1 publication Critical patent/FR2389598A1/fr
Application granted granted Critical
Publication of FR2389598B1 publication Critical patent/FR2389598B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FR7713890A 1975-12-17 1977-05-06 Expired FR2389598B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/641,419 US4033941A (en) 1975-12-17 1975-12-17 Process for purifying glucagon

Publications (2)

Publication Number Publication Date
FR2389598A1 FR2389598A1 (fr) 1978-12-01
FR2389598B1 true FR2389598B1 (fr) 1981-06-19

Family

ID=24572291

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7713890A Expired FR2389598B1 (fr) 1975-12-17 1977-05-06

Country Status (7)

Country Link
US (1) US4033941A (fr)
CA (1) CA1089448A (fr)
DE (1) DE2721027A1 (fr)
FR (1) FR2389598B1 (fr)
GB (1) GB1576344A (fr)
NL (1) NL7703758A (fr)
SE (1) SE443512B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1284000C (fr) * 1985-07-01 1991-05-07 David Gregory Maskalick Procede de recuperation du glucagon dans le pancreas
US4617376A (en) * 1985-07-01 1986-10-14 Eli Lilly And Company Process for recovering glucagon from pancreas glands
JP5550338B2 (ja) * 2006-07-31 2014-07-16 ノボ・ノルデイスク・エー／エス ペグ化持続型インスリン
CN101541830A (zh) * 2006-09-22 2009-09-23 诺沃-诺迪斯克有限公司 蛋白酶抗性的胰岛素类似物
ES2563038T3 (es) * 2007-04-30 2016-03-10 Novo Nordisk A/S Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca
JP5675347B2 (ja) * 2007-06-01 2015-02-25 ノボ・ノルデイスク・エー／エス 安定した非水性薬学的組成物
ES2618073T3 (es) * 2008-03-14 2017-06-20 Novo Nordisk A/S Análogos de insulina estabilizados frente a proteasas
EP2910571B1 (fr) 2008-03-18 2016-10-05 Novo Nordisk A/S Analogues de l'insuline acylés, stabilisés à la protéase
CA2870313A1 (fr) 2012-04-11 2013-10-17 Novo Nordisk A/S Formulations a base d'insuline
WO2015052088A1 (fr) 2013-10-07 2015-04-16 Novo Nordisk A/S Nouveau dérivé d'un analogue de l'insuline
MX2019006463A (es) 2016-12-16 2019-08-14 Novo Nordisk As Composiciones farmaceuticas que contienen insulina.
EP3517543B1 (fr) 2018-01-30 2020-11-04 Bachem AG Fabrication de peptides de glucagon
CN113024658B (zh) * 2019-12-25 2022-10-21 翰宇药业（武汉）有限公司 一种纯化利拉鲁肽的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3715345A (en) * 1970-08-03 1973-02-06 Lilly Co Eli Glucagon separation process
DE2258080C3 (de) * 1972-11-27 1981-12-17 Eli Lilly And Co., Indianapolis, Ind. Verfahren zur Gewinnung von Hexatriacontapeptiden
US3878186A (en) * 1973-05-09 1975-04-15 Lilly Co Eli Process for purifying insulin
US3875138A (en) * 1973-09-27 1975-04-01 Lilly Co Eli Process for recovering glucagon

Also Published As

Publication number Publication date
US4033941A (en) 1977-07-05
NL7703758A (nl) 1978-10-09
SE7705162L (sv) 1978-11-04
SE443512B (sv) 1986-03-03
CA1089448A (fr) 1980-11-11
DE2721027A1 (de) 1978-11-16
FR2389598A1 (fr) 1978-12-01
GB1576344A (en) 1980-10-08

Similar Documents

Publication Publication Date Title
FR2389598B1 (fr)
JPS5423292B2 (fr)
JPS5211053U (fr)
JPS51110899U (fr)
JPS5270916U (fr)
JPS5634394Y2 (fr)
JPS5410186Y2 (fr)
JPS5222298U (fr)
CH603779A5 (fr)
CH603101A5 (fr)
CH607067A5 (fr)
CH606968A5 (fr)
CH584804B5 (fr)
CH606683A5 (fr)
CH606207A5 (fr)
CH605462A5 (fr)
CH605165A5 (fr)
CH604800A5 (fr)
CH604746A5 (fr)
CH604600A5 (fr)
CH604586A5 (fr)
CH604214A5 (fr)
CH585833A5 (fr)
CH603814A5 (fr)
CH602630A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse